SSShalina Kaur Harminder Singh

Shalina Kaur Harminder Singh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects

Research Interests


Shalina Kaur Harminder Singh has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Aneeza Wan Hamizan

    Department of Otorhinolaryngology, Faculty of Medicine, Universiti Kebangsaan Malaysia

    1 shared publication
  • Farah Dayana Zahedi

    Department Otorhinolaryngology and Head and Neck Surgery, Faculty of Medicine, University Kebangsaan Malaysia, Kuala Lumpur, Malaysia

    1 shared publication
  • Salina Husain

    Department of Otorhinolaryngology-Head and Neck Surgery, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia

    1 shared publication
  • Siti Norlia Othman

    Department of Medical Microbiology and Immunology, Faculty of Medicine, Universiti Kebangsaan Malaysia

    1 shared publication
  • Zetti Zainol Rashid

    Department of Microbiology and Clinical Immunology, Faculty of Medicine, University Kebangsaan Malaysia, Kuala Lumpur, Malaysia

    1 shared publication

Latest Publications

  • Open Access

    Smell Outcome and Seropositivity Titre in Post-COVID-19 Patients

    by Shalina Kaur Harminder Singh, Salina Husain, Aneeza Khairiyah Wan Hamizan, Farah Dayana Zahedi, Siti Norlia Othman, Zetti Zainol Rashid

    Introduction: The aims of the study were to perform an olfactory assessment on patients active and post-COVID-19 using the culturally adapted Malaysian version Sniffin’ Sticks identification smell test (mSS-SIT), to evaluate the patient olfactory outcome using a Malay short version of the Questionnaire of Olfactory Disorders-Negative Statements (msQOD-NS), as well as to evaluate seropositive titre (IgG) response using automated serology method. Methods: Score for mSS-SIT was performed during the hospitalization, when patients had tested positive for SARS-CoV-2 (during COVID-19), and repeated after they had tested negative (after COVID-19). Also, each patient completed msQOD-NS and serology SARS-CoV-2 antibodies blood test was evaluated. Results: During COVID-19, 2 of our patients were anosmia (6.5%), 22 (70.9%) were hyposmia, and 7 (22.6%) were normosmia. We repeated mSS-SIT on these same patients after COVID-19, and none of these subjects were hyposmia or anosmia, as they achieved a score >12. All our patients had scored 21 using msQOD-NS, meaning no impact on quality of life as they had regained their normal olfactory function. In this study also, we obtained no correlation between smell test and seropositivity titre COVID-19, and antibody levels gradually decreased over time till 6 months and remained stable up to 12 months. Conclusion: From this study, we know full recovery of the sense of smell can be expected post-COVID-19 infection and COVID-19 antibody persists in the body up to 12 months of infection.